1. Home
  2. TFPM vs TMDX Comparison

TFPM vs TMDX Comparison

Compare TFPM & TMDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TFPM
  • TMDX
  • Stock Information
  • Founded
  • TFPM 2016
  • TMDX 1998
  • Country
  • TFPM Canada
  • TMDX United States
  • Employees
  • TFPM N/A
  • TMDX N/A
  • Industry
  • TFPM Precious Metals
  • TMDX Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • Sector
  • TFPM Industrials
  • TMDX Health Care
  • Exchange
  • TFPM Nasdaq
  • TMDX Nasdaq
  • Market Cap
  • TFPM 4.3B
  • TMDX 4.8B
  • IPO Year
  • TFPM N/A
  • TMDX 2019
  • Fundamental
  • Price
  • TFPM $23.16
  • TMDX $109.88
  • Analyst Decision
  • TFPM Strong Buy
  • TMDX Buy
  • Analyst Count
  • TFPM 3
  • TMDX 9
  • Target Price
  • TFPM $23.67
  • TMDX $129.88
  • AVG Volume (30 Days)
  • TFPM 463.5K
  • TMDX 813.0K
  • Earning Date
  • TFPM 08-06-2025
  • TMDX 07-30-2025
  • Dividend Yield
  • TFPM 0.95%
  • TMDX N/A
  • EPS Growth
  • TFPM N/A
  • TMDX N/A
  • EPS
  • TFPM 0.02
  • TMDX 1.41
  • Revenue
  • TFPM $293,708,000.00
  • TMDX $488,227,000.00
  • Revenue This Year
  • TFPM $19.66
  • TMDX $34.07
  • Revenue Next Year
  • TFPM $0.85
  • TMDX $20.76
  • P/E Ratio
  • TFPM $929.82
  • TMDX $77.97
  • Revenue Growth
  • TFPM 39.01
  • TMDX 64.43
  • 52 Week Low
  • TFPM $13.94
  • TMDX $55.00
  • 52 Week High
  • TFPM $25.45
  • TMDX $177.37
  • Technical
  • Relative Strength Index (RSI)
  • TFPM 46.45
  • TMDX 33.58
  • Support Level
  • TFPM $22.70
  • TMDX $109.59
  • Resistance Level
  • TFPM $24.15
  • TMDX $120.45
  • Average True Range (ATR)
  • TFPM 0.68
  • TMDX 5.67
  • MACD
  • TFPM -0.15
  • TMDX -2.30
  • Stochastic Oscillator
  • TFPM 24.21
  • TMDX 1.07

About TFPM Triple Flag Precious Metals Corp.

Triple Flag Precious Metals Corp is a streaming and royalty company focused on precious metals. Its revenues are largely generated from a diversified portfolio of properties in Australia, Canada, Colombia, Cote d'Ivoire, Mexico, Mongolia, Peru, South Africa, and the United States. Its diversified portfolio of streams and royalties comprises long-life mining assets, including the Northparkes copper-gold mine in Australia, the Cerro Lindo polymetallic mine in Peru, the Fosterville gold mine in Australia, the Buritica gold mine in Colombia, and the Impala Bafokeng Operations in South Africa among others. A majority of its revenue is derived through its interests in various gold streams. Geographically, the company derives maximum revenue from Australia, followed by Peru and other regions.

About TMDX TransMedics Group Inc.

TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System(OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The Company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.

Share on Social Networks: